Tata Chemicals FY26: Volumes up, pricing down, and a major US reset

Tata Chemicals closed FY26 with steady operating volumes but weaker profitability, as soda ash realizations stayed under pressure across geographies. For Q4 FY26, consolidated revenue was INR 3,438 crore versus INR 3,509 crore a year ago. EBITDA fell to INR 274 crore from INR 327 crore. For the full year, consolidated revenue came in at INR 14,584 crore compared with INR 14,887 crore in FY25, while EBITDA declined to INR 1,805 crore from INR 1,953 crore.

The quarter also carried a large exceptional impact in the US. The company recognized an impairment charge of INR 1,837 crore on goodwill and a deferred tax asset write-off of INR 182 crore amid current soda ash market conditions. Management described FY26 as a difficult operating environment, driven by excess capacity, weak macro conditions, and unremunerative pricing in export markets such as Southeast Asia.

What moved the numbers in Q4 and FY26

The quarterly sales bridge showed a 2% decline in revenue, with the company attributing the change to lower realizations and lower volumes in the US and UK, partly offset by higher volumes in India and Kenya. The EBITDA bridge pointed to a 16% decline versus Q4 FY25, with fixed costs being a meaningful drag in the quarter.

For the full year, the revenue bridge indicated a 2% decline, where higher volume and mix contributed positively but was outweighed by a price impact. EBITDA for FY26 fell 8% year on year, with lower realizations being the key negative, partly offset by higher volumes and fixed-cost control.

A notable element in Tata Chemicals’ narrative is that, while soda ash remains cyclical, it is trying to broaden its earnings base. Management highlighted that non-soda ash revenue grew 14% from INR 6,118 crore in FY25 to INR 6,946 crore in FY26.

Note: PAT figures are stated as continuing operations before exceptional items (as per presentation).

Unit performance: India resilience, US pain, and a leaner UK

Unit-wise disclosures show how differently the cycle played out across geographies.

India performed better on volumes after capacity additions, and the Mithapur facility achieved 1 million tons of soda ash production during the year. However, realizations were lower, and the company noted higher variable and fixed costs as well as higher depreciation following expansion capitalization.

The US was the weakest spot in the portfolio during FY26. The company cited lower volumes and unremunerative realizations for exports, particularly into Southeast Asia. The large goodwill impairment was recorded as an exceptional item in FY26. On the call, management also stated it would not sell into unremunerative markets, and that it has stopped such sales after honoring one pre-existing shipment.

The UK’s reported base changed structurally after the Lostock soda ash plant cessation in January 2025. Management said the closure helped stem ongoing EBITDA erosion and lowered the fixed-cost base. In Q4 FY26, UK EBITDA turned negative, which management attributed to a proactive decision to prepone a shutdown originally planned for April into March to enable a better run next year.

Kenya saw higher volumes but was offset by weaker realizations and higher fixed costs. The company operationalized a 50 kilo ton electric calciner soda ash capacity and noted a 5MW solar plant and solar pond being operational.

Rallis, where Tata Chemicals holds 55.04%, recorded revenue growth and positive commentary around crop care and seeds, though the results also carried an exceptional item related to labour codes.

Strategy and capital allocation: non-soda ash push continues

Beyond the cycle commentary, the company framed its strategy around three broad priorities: ESG focus, operational excellence through innovation and digitalization, and portfolio expansion beyond soda ash.

The presentation outlined a pipeline of projects with specific timelines and capex, including IVSD salt capacity additions and a precipitated silica plant in Cuddalore. On the earnings call, management also linked several projects to return expectations. For the near-term IVSD debottlenecking, management cited a return above 20%. For the precipitated silica capex, it spoke of roughly 15% to 20% at the low to high end, while also emphasizing logistics advantages from being located in South India.

The company also completed the acquisition of Novabay Pte Limited in Singapore on 19 March 2026, adding premium-grade bicarbonate capacity. This aligns with management’s focus on growing less cyclical revenue streams.

In terms of forward spending, the CFO guided that FY27 capex would be around INR 1,300 crore. It is expected to be split between maintenance capex in major sites such as Mithapur and the US, and growth capex in South India, Singapore, and select projects such as Valinokkam and silica. The CFO also said net debt is expected to remain broadly at similar levels as March 2026, given continued pressure on the business.

Risks and what investors should track

Management highlighted that the Middle East conflict has increased energy, raw material, shipping, and transportation costs. The company said it is passing through logistics costs contractually, and that input cost increases have been transparently communicated and passed on where possible. Still, it flagged Kenya as a watch area because it depends on HFO sourced from the Middle East and requires active monitoring for alternate sources.

The global soda ash setup remains the dominant variable. Management expects near-term demand growth to be broadly flat, constrained by weak macro and excess capacity. China inventories remain elevated, and pricing is expected to remain range-bound and reactive to energy cost movements.

At the same time, Tata Chemicals sees medium-to-long-term support from sustainability-driven demand such as solar PV and EV-linked applications. Management also discussed incremental dense ash demand from solar glass, suggesting initial demand in the range of 7,500 to 10,000 tons per month when units run.

Closing takeaways

FY26 for Tata Chemicals was defined by volumes holding up but pricing staying weak, particularly for exports. The US impairment underlines how sharply the soda ash cycle has turned. Against that backdrop, the company is emphasizing disciplined market participation, maintaining cost and cash discipline, and shifting the portfolio toward non-soda ash revenue streams.

The next few quarters will likely be judged on two things: whether soda ash realizations stabilize, and how effectively the company converts its capacity additions and acquisitions into steadier, less cyclical earnings. The company’s capex guidance and return thresholds suggest a cautious approach, but the cycle will remain the key swing factor for consolidated profitability.